Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Acelyrin Inc (SLRN)

Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Acelyrin Inc 4149 Liberty Canyon Road Agoura Hills CA 91301 USA

www.acelyrin.com Employees: 130 P: 805-730-0360

Description:

Acelyrin Inc. is a clinical biopharma company. It focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep. Acelyrin Inc. is based in Agoura Hills, California.

Key Statistics

Overview:

Market Capitalization, $K 593,858
Enterprise Value, $K 375,758
Shares Outstanding, K 99,808
Annual Sales, $ 0 K
Annual Net Income, $ -381,640 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -85,670 K
EBIT, $ -375,330 K
EBITDA, $ -385,710 K
60-Month Beta 1.98
% of Insider Shareholders 13.60%
% of Institutional Shareholders 87.31%
Float, K 86,234
% Float 86.40%
Short Volume Ratio 0.45

Growth:

1-Year Return -35.33%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.86 on 08/13/24
Next Earnings Date 11/13/24 [AMC]
Earnings Per Share ttm -2.84
EPS Growth vs. Prev Qtr -138.89%
EPS Growth vs. Prev Year -53.57%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SLRN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -46.10%
Return-on-Assets % -41.46%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.05
Book Value/Share 5.74
Interest Coverage -4.77
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar